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Abstract
Colibacillosis results from infection with avian pathogenic Escherichia coli bacteria. Healthy broilers are resistant to inhaled E.
coli, but previous infection with vaccine or virulent strains of Infectious Bronchitis Virus (IBV) predisposes birds for severe
colibacillosis. We investigated whether IBV affects recruitment and function of phagocytic cells and examined NO production,
phagocytic and bactericidal activity, and kinetics of peripheral blood mononuclear cells (PBMC) and splenocytes. Moreover, we
measured cytokine mRNA expression in lung and spleen samples. Broilers were inoculated with IBVH120 vaccine or virulent M41
and challenged 5 days later with E. coli 506. A PBS control and E. coli group without previous virus inoculation were also included.
Birds were sacrificed at various time points after inoculation (h/dpi). Inoculation with IBV induced extended and more severe
colibacillosis than with E. coli alone. At 4 dpi, the number of KUL-01+ PBMC in all E. coli-inoculated groups was significantly
higher than in PBS-inoculated birds, which correlated with lesion scores. From 1 to 4 dpi, NO production by PBMC from all E. coli-
inoculated animals was elevated compared to PBS birds. Bactericidal activity of PBMC in IBV-inoculated animals at 7 dpi was
lower than in PBS- and E. coli-inoculated birds, but phagocytic capacity and recruitment were not severely impaired. In spleen
samples of IBV-infected animals reduced expression of IL-1b, IL-6, IL-8, IL-10, IL-18 and IFN-g mRNA was found 1 dpi. Our
results suggest that enhanced colibacillosis after IBV infection or vaccination is caused at least by altered innate immunity and less
by impairment of phagocytic cell function.
# 2008 Elsevier B.V. All rights reserved.
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1. Introduction
Predisposition for bacterial infections in the course
of respiratory viral infections is found in various
species, both avian and mammalian. In chickens,
turkeys and ducks colibacillosis is often observed
secondary to infection with respiratory agents e.g.
Infectious Bronchitis Virus (IBV), Newcastle Disease
Virus, and Mycoplasma gallisepticum (Igbokwe et al.,
1996; Nakamura et al., 1994). In mice, influenza virus
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increases susceptibility to Streptococcus pneumoniae
infection (Seki et al., 2004; Speshock et al., 2007) and
measles virus predisposes for a range of bacterial
infections such as Listeria monocytogenes (Slifka et al.,
2003). In cattle, susceptibility for pneumonic pasteur-
ellosis is greatly enhanced by a variety of respiratory
viruses including bovine respiratory syncytial virus (Liu
et al., 1999), bovine herpes virus-1 (Leite et al., 2002)
and bovine coronavirus (Storz et al., 2000). In man,
pneumonia has been a leading cause of death during
influenza pandemics, supporting the widely held view
that influenza virus predisposes for streptococcal
infections (McCullers, 2006).
The mechanisms behind enhanced susceptibility to
bacterial superinfection after viral infection have been
studied extensively (Beadling and Slifka, 2004; Hament
et al., 1999) but are still not well understood. A first set of
hypotheses suggests increased susceptibility due to tissue
damage in the respiratory tract resulting in functional
impairment. Three possible causes have been described
as mechanisms for functional damage. Viral replication
in the upper respiratory tract causes loss of cilia and
ciliated cells (Bakaletz, 1995), decreased ciliary activity
impairs mucociliary clearance (Wilson et al., 1996) and
finally, damage to epithelium may provide more
attachment sites for bacteria (Ahmer et al., 1999).
A second set of hypotheses suggests altered innate
immune responses. Impairment of innate effector
functions, i.e. adhesion and entry, phagocytosis, killing,
nitric oxide (NO) and superoxide production have been
suggested previously (Ficken et al., 1987; Naqi et al.,
2001; Read et al., 1999). Changes in recruitment or
function of macrophages and neutrophils after bacterial
superinfections have been described in mice (Navarini
et al., 2006; Slifka et al., 2003).
Modulation of other innate functions affecting
induction and/or control of adaptive responses might
have a long term effect upon the host–pathogen
interaction. Type I interferons (IFNs I) induced after
viral infection have an antiviral effect, but can be
detrimental for induction of anti-bacterial responses
(Navarini et al., 2006; O’Connell et al., 2004), whereas
type II IFNs play an important role in bacterial
infections (Shtrichman and Samuel, 2001).
Goren (1978) developed an experimental model in
broilers that demonstrated enhanced susceptibility to
Escherichia coli after inoculation with IBV. Moreover,
not only a virulent strain (IBV M41) enhanced
inflammatory reactions on superinfection with E. coli,
but the mild IBV vaccine strain (IBV H120) widely
used in the field also enhanced susceptibility in a very
similar way (Matthijs et al., 2003).
In our study to investigate which mechanisms
underlie enhanced susceptibility to colibacillosis after
IBV infection or vaccination, we examined the
dynamics of pathogens and of immunopathological
changes (Matthijs et al., accepted for publication).
The aim of this study was to detect whether innate
effector functions such as the recruitment of effector
cells and function of phagocytic cells, measured by NO
production and bactericidal capacity, had been affected
after IBV infection. As an alternative explanation for the
enhanced colibacillosis we also examined altered
expression of cytokine mRNA in spleen and lung
samples.
2. Materials and methods
2.1. Experimental chickens
Eighteen-day-incubated eggs originating from a
Mycoplasma gallisepticum-free broiler parent (Cobb)
flock were obtained from a commercial hatchery and
hatched at the research facility of the Department of
Farm Animal Health (Utrecht University). From day of
hatch (day 1), broilers were housed in negative pressure
HEPA isolators (Beyer and Eggelaar, Utrecht, The
Netherlands) each with a volume of 0.68 m3 and fitted
with a wire floor of 0.93 m2. Isolators were ventilated at
a rate of approximately 40 m3 h1. Broilers were fed a
commercial ration containing 12.4 MJ of metabolically
energy per kg and 19.5% crude protein ad libitum, but
from day 14 onwards feed was restricted to 75% of ad
libitum intake to diminish leg disorders and hydrops
ascites. Tap water was provided ad libitum throughout
the experimental period. Up to the start of feed
restriction, 22 h light was given per 24 h; thereafter it
was reduced to 16 h. From day 4 onwards red light was
given to prevent cannibalism. Isolator temperature was
gradually decreased from 35 8C at day 1 to 20 8C at day
31. From day 31 to the end of the experiment isolator
temperature was kept at approximately 20 8C. All
chickens were housed, handled and treated following
approval by the Animal Experimental Committee of the
Veterinary Faculty of Utrecht University, The Nether-
lands, in accordance with the Dutch regulation on
experimental animals.
2.2. Inocula
The IB vaccine virus H120 was obtained as
commercial freeze-dried 1000 doses vials which
contained at least 103.0 EID50 (egg infective dose
50%) per dose (Nobilis1 IB H120; batch 041106A).
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ThevirulentMassachusetts IBV strainM41was obtained
from Intervet, Boxmeer, the Netherlands, as freeze-dried
vials containing 108.3 EID50/1.2 ml/vial. The virus had
been passaged twice in SPF embryonated eggs. All IBV
inocula were prepared in distilled water just prior to use
and contained at least 103.0 EID50/ml of H120 virus and
104.6 EID50/ml of M41 virus. The Escherichia coli strain
506 (O78; K80) was isolated from a commercial broiler
(Van Eck and Goren, 1991). The E. coli culture was
prepared as described by Matthijs et al. (2003) and was
used at a concentration of 107.6 CFU/ml.
2.3. Experimental design
At day 1, broilers were randomly divided into four
groups of 30 chickens each. Each group was housed in a
separate isolator. At 27 days of age, all groups were
inoculated oculo-nasally (one droplet of 0.05 ml per bird
in each eye and nostril) and intratracheally (1 ml per
bird): groups 1 and 2 received distilled water, group 3
received IBVH120 virus and group 4 IBVM41 virus. At
32 days of age, groups 2, 3 and 4 were intratracheally
inoculated with 1 mlE. coli 506 culture per bird. Group 1
received 1 ml PBS-diluted glucose broth intratracheally
per bird. For convenience, we refer to group 1 (distilled
water and PBS broth) as PBS group, group 2 (distilled
water andE. coli broth) as theE. coli group, group 3 (IBV
H120 virus and E. coli broth) as the H120 group, and
group 4 (IBVM41 virus andE. coli broth) asM41 group.
2.4. Clinical and post-mortem examination
Clinical signs of IBV infection were determined 1, 2,
4 and 5 days after IBV inoculation and after E. coli
inoculation just before euthanizing. A bird was recorded
as having signs of IBV infection if mucous nasal
discharge was observed after mild pressure on the
nostrils (Matthijs et al., 2003).
From each group, 5 broilers were electrocuted and
blood collected at 0.5 h, 3 h and at days 1, 2, 4 and 7
after E. coli inoculation (hpi/dpi). At each time point,
colibacillosis lesions were scored macroscopically.
Lesion scoring was performed as described by Van
Eck and Goren (1991) in the left and right thoracic air
sac, pericardium and liver. Lesion scores ranged from 0
to 3 per organ, leading to a maximum score of 12 per
bird (Matthijs et al., 2005).
2.5. Flow cytometric analysis of cell composition
Peripheral blood, spleen and lung were collected
from sacrificed birds. Spleen tissue was squeezed
through a 70 mm mesh to prepare single cell suspen-
sions. Splenocytes and PBMC were isolated by density
gradient centrifugation for 20 min at 850  g using
Ficoll-Hypaque (density 1.078), washed twice with
PBS (Cambrex) and adjusted to 5  107 cells/ml in
RPMI1640 medium supplemented with 10% FBS,
2 mM glutamax-I (Gibco) and 100 U/ml penicillin and
streptomycin (Gibco).
Cell suspensions were fluorescently labeled for
30 min on ice with mAb against thrombocytes (mouse
anti-chicken CD41/CD61:FITC, Serotec), monocytes
(mouse anti-chicken monocyte/macrophage KUL-
01:FITC, Southern Biotechnology Associates) and
CD8+ cells (mouse anti-chicken CD8a:FITC, mouse
anti-chicken CD8b:RPE, Southern Biotechnology
Associates). Subsequently, cell-associated fluorescence
was analyzed by flow cytometry using Cell Quest
software (Becton Dickinson). Results are expressed as
percentages of total viable cells.
2.6. Nitric oxide production assay
Cells were seeded in flatbottom 96-well plates
at 2.5  106 cells in 50 ml culture medium
(RPMI1640 + 2% chicken serum + 2 mM glutamax-I
(Gibco) and 100 U/ml penicillin and streptomycin
(Gibco). Cells were incubated for 48 h at 41 8C (5%
CO2) with 100 ml of either culture medium to
determine background production of nitric oxide
(NO), medium supplemented with 10 mg/ml heat-
killedE. coli 506, ormediumwith 10 mg/mlE. coliLPS
(from E. coli O55:B5, Sigma) to measure maximum
NO production. After incubation, 50 ml/well of culture
supernatant was transferred to sterile flatbottom 96-
well plates. An NO dilution series (200–3.13 mM) was
included on each plate as a standard curve to determine
the amount of NO produced. To each well, 50 ml of
Griess reagent (1% sulfanilamide and 0.3% naphtyle-
nediamine, 1:1 in 2.5% phosphoric acid) was added,
plates were incubated for 10 min at room temperature
on a plate shaker and absorbance was recorded at
550 nm. For each chicken, NO secretion was calculated
as total amount of NO produced by the cells after
stimulation with heat-killed E. coli or E. coli LPS,
minus the background NO production by unstimulated
cells.
2.7. Phagocytosis and killing assay
Splenocytes and PBMCwere incubated for 30 min at
108 cells in 1 ml RPMI 1640, 5% FBS containing 109 E.
coli bacteria, in roundbottom 12 ml polypropylene
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tubes (Greiner Bio-One) at 37 8C, 5% CO2, to allow
bacterial adhesion and entrance. At this point,
gentamycin (200 mg/ml; Gibco) was added to each
tube to kill extracellular bacteria and cells were
incubated for an additional 30 min at 37 8C. Cells
were washed once with PBS to remove the gentamy-
cin, and either lysed directly with 1% saponin
(T = 0.5 h) to release intracellular bacteria, or incu-
bated for 14 h or 24 h in RPMI 1640 medium
supplemented with 5% FBS and 20 mg/ml gentamycin
before cell lysis. The cells were cultured in the
presence of gentamycin to prevent re-infection and
unlimited growth in the medium of E. coli released
from dead cells. After saponin treatment, cell lysates
were centrifuged and pellets were resuspended in
200 ml PBS and plated in duplicate (100 ml lysate per
plate) on McConky Agar (MCA) plates (Biotrading)
to determine the number of viable bacteria. The MCA
plates were incubated overnight at 37 8C and colonies
were counted blindly. Results were calculated as the
sum of colonies on the duplicate plates. If the sum
of colony counts on the duplicate plates was below
100 colonies, cells were considered successful in
clearing the E. coli, whereas cells were considered
unable to clear the bacteria when counts were over 300
colonies.
2.8. Real-time quantitative reverse transcription-
polymerase chain reaction (RT-PCR)
RNA samples isolated from spleen and lung were
screened for mRNA encoding IL-1b, IL-4, IL-6, IL-8,
IL-10, IL-18, IFNa, IFNb, and IFNg. Total RNA was
isolated using the RNeasy Mini Kit (Qiagen) following
the manufacturer’s instructions. Purified RNA was
eluted in 30 ml RNase-free water and stored at 80 8C.
Reverse transcription was performed using iScript
cDNA Synthesis Kit (Biorad). Primers and probes
(Applied Biosystems) were designed according to
Kaiser et al. (2003) and Rothwell et al. (2004) and
are listed in Table 1. For the quantitative RT-PCR assay
TaqMan Universal PCR Master Mix (Applied Biosys-
tems) was used. Primers were used at 300 nM and
probes at 100 nM concentration. Amplification and
detection of specific products was achieved with the
MyiQ Single-Color Real-Time PCR Detection System
(Bio-Rad) with the following cycle profile: one cycle of
50 8C for 2 min, one cycle of 95 8C for 10 min, and 40
cycles of 95 8C for 10 s and 59 8C for 1 min. Results
were expressed as fold changes between samples,
relative to the PBS group (Philbin et al., 2005). To
correct for variation in RNA preparation and sampling,
Ct values for cytokine-specific product for each sample
were standardized using the Ct value of 28S-specific
product for the same sample. To normalize RNA levels
between samples within an experiment, the mean Ct
value for 28S-specific product was calculated by
pooling Ct values of all samples in that experiment.
Well-to-well variations in Ct value of 28S-specific
product about the experimental mean were calculated.
The slope of the 28S dilution series regression lineswas
used to calculate differences in input of total RNA. Fold
differences in cytokine expression between treatment
groups were calculated relative to the reference
ribosomal RNA, using a method adapted from Philbin
et al. (2005). Fold differences were calculated from
the CT values C (for the cytokine) and C
0 (for
ribosomal RNA) using the equation 10logRðA=BÞ ¼
½ðCA  CBÞ=S  ½ðC0A  C0BÞ=S0, where S and S0 are,
respectively, the slopes of plots of CT value against the
10logarithm of concentration for serial dilutions of
cytokine DNA and ribosomal RNA, assayed on the
same plate. This calculation avoids assumptions about
the efficiency of the PCR amplifications and reduces to
the common DDCT method in the case that both have
perfect efficiency.
2.9. Statistical analysis
Between-group differences per time point were non-
parametrically analyzed for each assay using the Mann-
Whitney test. Partial correlations between different
assays were determined per time point, with treatment
as a control variable. Analysis was performed using the
SPSS program and the probability level for significance
was taken as P < 0.05.
3. Results
3.1. Clinical and macroscopical observations
Five days after IBV inoculation, all broilers in the
M41 group and 10% of the broilers in the H120 group
showed nasal discharge. Birds were examined
macroscopically for colibacillosis lesions (Fig. 1).
No lesions were observed in birds of the E. coli group
at 0.5 h and 3 h after E. coli inoculation, at these time
points all broilers of the H120 and the M41 groups,
except one in the H120 group, had airsacculitis.
Airsacculitis (colibacillosis lesions in the thoracic air
sacs) was observed in chickens of all E. coli-
inoculated groups between 1 and 4 dpi. At 7 dpi, no
signs of colibacillosis were observed anymore in the
E. coli group whereas all birds of the H120 and the
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M41 groups had airsaccullitis. Systemic lesions
(perihepatitis / pericarditis) were observed in 1 bird
of the H120 group and 2 birds of the M41 groups at
7 dpi. No macroscopical signs of colibacillosis were
observed in birds of the PBS group throughout the
course of the experiment. More detailed clinical data
can be found in Matthijs et al. (submitted for
publication).
3.2. Flow cytometric analysis of blood
mononuclear cells and splenocytes
The frequencies of thrombocytes, monocytes/macro-
phages, CD8b+ and CD8a+ cells were analyzed as
percentages of total viable cells in PBMC and
splenocyte cell suspensions by flow cytometry at 1,
2, 4 and 7 dpi. Thrombocytes accounted for 60–75% of
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Table 1
Real-time quantitative RT-PCR primers and probes
RNA target Probe/primer sequence (50–30) Accession
number
28S
Probe (FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA) X59733
F primer GGCGAAGCCAGAGGAAACT
R primer GACGACCGATTTGCACGTC
IL-1b
Probe (FAM)-CCACACTGCAGCTGGAGGAAGCC-(TAMRA) AJ245728
F primer GCTCTACATGTCGTGTGTGATGAG
R primer TGTCGATGTCCCGCATGA
IL-4
Probe (FAM)-AGCAGCACCTCCCTCAAGGCACC-(TAMRA) AJ621735
F primer AACATGCGTCAGCTCCTGAAT
R primer TCTGCTAGGAACTTCTCCATTGAA
IL-6
Probe (FAM)-AGGAGAAATGCCTGACGAAGCTCTCCA-(TAMRA) AJ309540
F primer GCTCGCCGGCTTCGA
R primer GGTAGGTCTGAAAGGCGAACAG
IL-8
Probe (FAM)-TCTTTACCAGCGTCCTACCTTGCGACA-(TAMRA) AJ009800
F primer GCCCTCCTCCTGGTTTCAG
R primer TGGCACCGCAGCTCATT
IL-10
Probe (FAM)-CGACGATGCGGCGCTGTCA-(TAMRA) AJ621614
F primer CATGCTGCTGGGCCTGAA
R primer CGTCTCCTTGATCTGCTTGATG
IL-18
Probe (FAM)-CCGCGCCTTCAGCAGGGATG-(TAMRA) AJ276026
F primer AGGTGAAATCTGGCAGTGGAAT
R primer ACCTGGACGCTGAATGCAA
IFNa
Probe (FAM)-CTCAACCGGATCCACCGCTACACC-(TAMRA) U07868
F primer GACAGCCAACGCCAAAGC
R primer GTCGCTGCTGTCCAAGCATT
IFNb
Probe (FAM)-TTAGCAGCCCACACACTCCAAAACACTG-(TAMRA) X92479
F primer CCTCCAACACCTCTTCAACATG
R primer TGGCGTGCGGTCAAT
IFNg
Probe (FAM)-TGGCCAAGCTCCCGATGAACGA-(TAMRA) Y07922
F primer GTGAAGAAGGTGAAAGATATCATGGA
R primer GCTTTGCGCTGGATTCTCA
PBMC and 2–4% of splenocytes, with no significant
differences between the treatment groups or fluctuations
in time (data not shown). The percentage monocytes in
peripheral blood of all E. coli-inoculated birds
increased up to 4 dpi, and at 7 dpi, dropped to levels
found in the PBS group (Fig. 2). A significant positive
correlation (P < 0.01) between monocyte percentages
and colibacillosis lesion scores was found at 4 dpi.
Whereas an effect of the E. coli inoculation on
monocyte frequencies was apparent, monocyte fre-
quencies were not significantly decreased or increased
in IBV-inoculated birds when compared to birds that
received E. coli only. In the spleen at 1 dpi, a
significantly higher percentage of macrophages was
found in IBV-infected birds, and only in the H120
group, a higher percentage of macrophages was found at
all time points. These changes were not significantly
correlated to lesion scores. Significant variations in the
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Fig. 1. Colibacillosis lesion scores at different time points after E. coli inoculation. Groups H120 andM41 were inoculated with their respective IBV
strains 5 days before E. coli inoculation, whereas the PBS group received no IBVor E. coli. Per treatment group, five birds were sampled at each time
point. Each dot represents the total lesion score of an individual bird with a maximum score of 12. The horizontal lines indicate the mean scores of
each treatment group. Birds with systemic signs of colibacillosis, characterized by lesions in liver and/or pericardium, are designated with ‘s’.
Groups with different letters are significantly different (P < 0.05).
Fig. 2. Percentage  S.D. of monocytes/macrophages (KUL-01) in PBMC and splenocytes at different time points after E. coli inoculation. Groups
H120 andM41 were inoculated with their respective IBV strains 5 days before E. coli inoculation, whereas the PBS group received no IBVor E. coli.
Bars represent the average frequency of labeled cells per treatment group (n = 5), as a percentage of total live cells. Groups with different letters are
significantly different (P < 0.05).
percentages of CD8b+, PBMC and splenocytes between
the treatment groups were observed at different time
points, but these variations were not related to an effect
of either E. coli or IBV (data not shown). Similar
fluctuations in the percentages of CD8a+b cells were
found, apart from 1 dpi, where the M41 group showed
higher percentages of CD8a+b cells than the other
groups, but no significant correlation was found with the
E. coli or IBV inoculation (data not shown).
3.3. Nitric oxide production
The Griess reaction assay was used to determine
whether IBV inoculation had an effect on the production
of NO by splenocytes and PBMC after subsequent
stimulation with heat-killed E. coli bacteria or E. coli
LPS. NO production by PBMC of the E. coli-inoculated
groups at 1 dpi was significantly higher than of the PBS
group (Fig. 3). Furthermore the IBV-inoculated groups,
most notably the H120 group, showed higher NO
production than the E. coli group, but at 2 dpi, NO
production of the IBV-inoculated groups almost halved.
At 7 dpi, NO production of the E. coli group had
dropped to the level of the PBS group, whereas NO
production by both the H120 and M41 groups was
elevated compared to the PBS and E. coli groups.
NO production by PBMC and splenocytes after E.
coli LPS-stimulation showed a pattern comparable to
stimulation with heat-killed E. coli, although the
amount of NO produced was approximately twice as
high (data not shown).
3.4. Phagocytosis and killing assay
The ability of PBMC and splenocytes to kill E. coli
bacteria after internalization was determined at 4 and
7 dpi, based on the number of colonies found after 24 h
incubation. Uptake of bacteria was confirmed after 14 h
incubation as the number of E. coli colonies retrieved
from the PBMC and splenocytes and was higher than
300 in all chickens (data not shown). At 7 dpi, in the
H120 andM41 groups the PBMC of 3 respectively 4 out
of 5 chickens did not kill engulfed bacteria based on
high colony counts, whereas only 1 chicken in the PBS
group and 1 chicken in the E. coli group did not kill
intracellular bacteria (Table 2). At 4 dpi, splenocytes
from all groups successfully killed E. coli bacteria. At
7 dpi however, splenocytes from 2 chickens in the H120
group were not able to kill the bacteria within 24 h
incubation (data not shown).
3.5. Real-time quantitative RT-PCR
To examine the effects of IBVand E. coli inoculation
on systemic immune functions, cytokine mRNA
expression of spleen and lung samples were measured
by real-time quantitative RT-PCR. No significant
differences between the groups were found at any time
point for IL-4, IFNa and IFNb in either spleen or lung
samples (data not shown). At 1 dpi, spleen mRNA
levels for IFNg and the pro-inflammatory cytokines IL-
1b and IL-6 (data not shown) as well as IL-8, IL-18 and
IFNg (Fig. 4A) were significantly upregulated in the E.
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Fig. 3. Means  S.E.M. of E. coli-induced NO production in response to heat-killed E. coli 506 by PBMC per group, at various time points after E.
coli inoculation. Groups H120 and M41 were inoculated with their respective IBV strains 5 days before E. coli inoculation, whereas the PBS group
received no IBVor E. coli. NO production by cells of individual chickens is calculated as the total NO production after stimulation with heat-killed E.
coli or LPS, minus the background NO production of unstimulated cells. Groups with different letters are significantly different (P < 0.05).
coli-inoculated group in comparison to the IBV-
inoculated groups. Similarly, mRNA levels for the
anti-inflammatory cytokine IL-10 was increased sig-
nificantly in E. coli-inoculated birds compared to the
IBV-inoculated birds. The mRNA levels of these
cytokines dropped sharply from 2 dpi onward. Inter-
estingly, at 7 dpi, only in the H120 group, IL-6, IL-10
and IFNgmRNA expression was still higher than the E.
coli group. Tests were carried out to find whether altered
expression of cytokine mRNA in IBV-inoculated birds
was also found in lung samples (Fig. 4B). In lung
samples, no significant differences between the groups
were found at any time point for IL-18, IFNb and IFNg
(data not shown). In contrast to our findings in the
spleen, at 3 hpi, mRNA levels for IL-6, IL-8, IFNg (data
not shown), IL-10 and IL-1b (Fig. 4B) in lung samples
of birds of the H120 and especially the M41groups were
higher than those of the E. coli group. However, at 1 dpi,
mRNA expression of these cytokines in the E. coli
group had increased similar to, or higher than that of the
birds in the IBV infected groups. Levels remained
elevated at 2 dpi, with highest expression in the IBV
H120 group. At 7 dpi, mRNA expression levels of all
three E. coli-inoculated groups had dropped to the level
of the birds of the PBS group.
4. Discussion
Enhanced susceptibility for bacterial infections as a
consequence of viral infection is reported in varying
combinations in various species (Hament et al., 1999).
In poultry, severe colibacillosis after infections with
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Table 2
Phagocytosis and killing of bacteria by PBMC of chickens killed 4 and
7 days after E. coli inoculation (dpi)
Group Colony counts 4 dpia Colony counts 7 dpia
<100 100–300 >300 <100 100–300 >300
PBMC
PBSb 3 0 2 0 4 1
E. coli 0 3 2 2 2 1
H120 0 2 3 1 1 3
M41 1 1 3 0 1 4
Birds were inoculated with Infectious Bronchitis Virus (IBV) vaccine
strain H120 (group: H120), virulent IBV strain M41 (group: M41) or
PBS (groups: PBS and E. coli) and 5 days later inoculated with E. coli,
the PBS group with PBS. Each group consisted of five broilers.
Numbers represent the number of chickens in each group displaying
the specified killing efficiency. For each chicken, samples were run in
duplicate.
a The number of colonies retrieved from phagocytic cells after lysis
was used as a measurement for killing efficiency; retrieval of less than
100 colonies was considered successful clearance, whereas retrieval of
more than 300 colonies was considered as a failure to clear E. coli.
b Inoculated at 32 days with glucose broth instead of E. coli broth.
Fig. 4. Real-time quantification of cytokine mRNA expression by cells isolated from (A) splenocytes and (B) lung tissue samples of PBS chickens
(white bars), chickens inoculated with E. coli only (black bars), IBV H120 + E. coli (hatched bars) and IBV M41 + E. coli (grey bars). Data are
expressed as mean relative fold increase at different time points after E. coli inoculation, compared to samples of PBS birds. Error bars show S.E.M.
for triplicate samples of five birds per treatment group. Groups with different letters are significantly different (P < 0.05).
Infectious Bronchitis Virus is well documented (Peigh-
ambari et al., 2000; Vandekerchove et al., 2004) and is a
serious problem in commercial chickens.
Interestingly, not only the virulent IBV M41 field
strain induces enhanced susceptibility to subsequent E.
coli infection, but the mild H120 vaccine strain also
induces this enhanced colibacillosis to about the same
level (Matthijs et al., 2003). A model based on these
findings was used to study the phenomenon and test the
contribution of different possible factors causing the
phenomenon. In a separate paper, we addressed the
question whether local changes at the surfaces of the
trachea, lung and airsacs might facilitate local bacterial
growth and subsequent entry of bacteria. The results of
that study showed that the clearance of the bacteria from
the lung was comparable for all the groups inoculated
with E. coli, irrespective of previous exposure to virus
(Matthijs et al., submitted for publication).
In this paper we examined whether prior exposure to
IBV virus (M41 or H120) affected the effector functions
of mononuclear cells resulting in the phenomenon of
enhanced susceptibility, a hypothesis supported by
several papers (Ficken et al., 1987; Naqi et al., 2001;
Slifka et al., 2003). For this question, NO production by
mononuclear cells isolated from the spleen and PBMC
were tested. After E. coli inoculation, the NO
production in samples upon stimulation with heat-
killed E. coli bacteria or E. coli LPS (data not shown)
was strongly increased in all groups, irrespective of
prior exposure to IBV, although at 1 dpi the increasewas
highest in IBV-inoculated birds. Another difference was
observed at 7 dpi, where birds exposed to E. coli alone
showed diminished NO production compared to birds
also exposed to either IBV strain (M41 or H120). This is
in line with the clinical picture of bacterial persistence
in broilers previously exposed to IBV.
Subsequently, the internalization and intracellular
killing of bacteria was tested in splenocytes and PBMC
of all groups. Again all groups exposed to E. coli,
irrespective of earlier exposure to IBV, responded
similarly in the assay at 4 dpi, in that the cells had a
diminished killing capacity. At a later time point (7 dpi),
bactericidal capacity in the groups exposed to IBV was
still lower than the bactericidal capacity of the group
exposed to E. coli alone, suggesting a slower recovery.
This once more was in line with the clinical recovery
observed in the E. coli alone group.
The results of the NO production and of the
internalization and intracellular killing of bacteria by
the individual splenocytes or PBMCs suggest that the
small changes in effector functions of those cells cannot
be the only reason for the phenomenon of enhanced
colibacillosis in animals previously exposed to virus.
However, changes in the number of cells and/or their
recruitment could still influence the outcome of the
secondary infection. We therefore evaluated the
percentage of effector cells by FACS analysis. Major
differences that could explain the enhanced colibacil-
losis in the samples of the dual infected groups were not
found.
Because no major changes in the effector functions
of the mononuclear cells could be found to explain the
phenomenon of enhanced colibacillosis, other mechan-
isms to explain the findings were sought. Supported by
the observation that clinical colibacillosis seemed
mainly the result of a systemic effect, and not directly
of a local lung condition, we set out to find other
explanations and looked at whether cytokine profiles
would clarify the clinical picture. This might lead to
insights into how the innate capacity of the animals was
modulated at the time of E. coli exposure. Therefore, we
examined mRNA expression in splenocytes and in
samples of the lung.
After E. coli inoculation alone, the pro-inflammatory
cytokines IL-1b and IL-6 were strongly increased in
both splenocytes and lung tissue. This was expected,
because both cytokines play an important role in
initiating an acute-phase immune response against
invading pathogens and activating a wide range of
immune cells such as macrophages and T-cells (Wigley
and Kaiser, 2003).
The pro-inflammatory chemokine IL-8 was found to
be upregulated in lung samples as early as 3 hpi, and in
splenocytes at 1 dpi. The findings in the lung are in
agreement with its function as a chemotractant,
produced at the infection site in order to recruit
heterophils and initiate a rapid local inflammatory
response (Withanage et al., 2004). The upregulation in
spleen samples was only found in the E. coli group and
is likely due to the fact that the bacteria are not retained
in the respiratory tract but spread systemically.
Surprisingly, in the IBV groups no IL-8 mRNA is
found in the spleen, which might suggest that a lack of
response in the spleen can contribute to prolonged
colibacillosis. The mRNA expression of pro-inflamma-
tory mediators IL-1b and IL-6 in the spleen at 1 dpi in
IBV groups also lagged behind that of the E. coli group.
Not only the cytokines IFNg and IL-18, but also IL-
10 were found to be upregulated in splenocytes and lung
samples of birds inoculated with E. coli alone. IFNg is a
potent macrophage-activating factor and IL-18 is an
important inducer of IFNg production (Wigley and
Kaiser, 2003). Both IFNg and IL-18 are strongly linked
to a cell-mediated Th1-like immune response (Staeheli
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et al., 2001). IL-10 on the other hand is a promotor of
Th2-like immune responses, predominantly by inhibit-
ing pro-inflammatory and Th1 cytokines (Rothwell
et al., 2004), which can increase host susceptibility to
bacterial diseases through its anti-inflammatory effects,
including suppression of macrophage function. Pre-
vious studies in chickens showed that IL-10 production
could be accompanied by either downregulation of
IFNg production (Abdul-Careem et al., 2007; Rothwell
et al., 2004), but also by concurrent upregulation of IL-
10 and IFNg (Hong et al., 2006). Moreover, it should be
noted that IL-10 is known to have immunostimulatory
effects in certain species, inducing MHC class II
upregulation and cytotoxic T-cell stimulation (Groux
and Cottrez, 2003).
In our chicken model, we find that high mRNA
expression of pro- and anti-inflammatory cytokines at
1 dpi in spleen samples is not found in the birds that
were inoculated with IBVand E. coli, but only in the E.
coli inoculated birds, and thus seems to be associated
with recovery of colibacillosis. The differences in
mRNA expression are consistent with the finding that
virus-induced modulation of the immune response plays
an important role in the susceptibility to subsequent
bacterial infection.
In conclusion, we observed that both vaccine and
virulent IBV caused enhanced colibacillosis, but IBV
did not significantly affect phagocytic capacity and NO
production of peripheral mononuclear cells and
splenocytes. However, IBV did alter the systemic
cytokine mRNA expression patterns after E. coli
inoculation in commercial broilers likely resulting in
enhanced colibacillosis.
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